Associations of plasma n3 polyunsaturated fatty acids with blood pressure and cardiovascular risk factors among Chinese

International Journal of Food Sciences and Nutrition

Volumn 63, Issue 6, 2012, Pages 667-673

  Huang, Tao ^a,b   Shou, Tianxing ^a,b   Cai, Nidan ^a,b   Wahlqvist, Mark L ^a,b,c   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cardiovascular diseases; Hypertension; Phospholipids; Polyunsaturated fatty acid; Prevalence

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; ARTICLE; ASIAN; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RISK; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84865318217     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2011.652076     Document Type: Article

References (44)

1. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, et al. 1992. A prospective study of nutritional factors and hypertension among US men. Circulation 86(5): 1475-1484.
2. Appel LJ, Miller ER, Seidler AJ, Whelton PK. 1993. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153(12):1429-1438. (Pubitemid 23191050)
3. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. 1990. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension -a population-based intervention trial from the Tromso Study. New Eng JMed 322(12):795-801. (Pubitemid 20094142)
4. Breslow JL. 2006. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83(6):1477S-1482S. (Pubitemid 44713088)
5. Cambien F, Warnet JM, Vernier V, Ducimetiere P, Jacqueson A, Flament C, et al. 1988. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol 127(1):75-86. (Pubitemid 18034368)
6. Chin JPF, Gust AP, Nestel PJ, Dart A. 1993. Marine oils dosedependently inhibit vasoconstriction of forearmresistance vessels in humans. Hypertension 21(1):22-28. (Pubitemid 23006448)
7. Cicero AFG, Derosa G, Di Gregori V, BoveM, Gaddi AV, Borghi C. 2010. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin ExpHypertension 32(2):137-144.
8. Cicero AFG, Ertek S, Borghi C. 2009. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 7(3):330-337.
9. Danthi SJ, Enyeart JA, Enyeart JJ. 2005. Modulation of native T-type calcium channels by omega-3 fatty acids. Biochem Biophys Res Commun 327(2):485-493. (Pubitemid 40040501)
10. Debacker G, Decraene I, Rosseneu M, Vercaemst R, Kornitzer M. 1989. Relationship between serum cholesteryl ester composition, dietary habits and coronary risk factors in middle-aged men. Atherosclerosis 78(2-3):237-243. (Pubitemid 19195495)
11. Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, et al. 2008. Dietary n-3 polyunsaturated fatty acids and direct rennin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 51(2):540-546. (Pubitemid 351156445)
12. Frenoux JMR, Prost ED, Belleville JL, Prost JL. 2001. A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats. J Nutr 131(1):39-45. (Pubitemid 32060620)
13. Grimsgaard S, Bonaa KH, Jacobsen BK, Bjerve KS. 1999. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 34(3):478-483. (Pubitemid 29426767)
14. Geleijnse JM, Giltay EJ, Grobbee DE, Donders ART, Kok FJ. 2002. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20(8): 1493-1499. (Pubitemid 34921171)
15. Gu D, Reynolds K,Wu X, Chen J, Duan X, Muntner P, et al. 2002. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 40(6):920-927. (Pubitemid 35434917)
16. Huang T, Bhulaidok S, Cai ZZ, Xu TC, Xu F, Wahlqvist ML, Li D 2010a. Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 54(11): 1628-1635.
17. Huang T, Tucker K, Lee Y, Crott J, Parnell L, Shen J, et al. 2010b. MAT1A variants modulate the effect of dietary fatty acids on plasma homocysteine concentrations. Nutr Metab Cardiovasc Dis [Epub ahead of print].
18. Huang T, Wahlqvist ML, Li D. 2010c. Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism. Nutrition 26(1):112-119.
19. Huang T, Wahlqvist ML, Xu TC, Xu A, Zhang AZ, Li D. 2010d. Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. Mol Nutr Food Res 54:S112-S119.
20. Jayasooriya AP, Begg DP, Chen N, Mathai ML, Sinclair AJ, Wilkinson-Berka J, et al. 2008. Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats. Prostaglandins Leukot Essent Fatty Acids 78(1):67-72.
21. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. 2005. Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217-223. (Pubitemid 40138015)
22. Li D, Mann NJ, Sinclair AJ. 2006. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids 41(1):85-89.
23. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ, et al. 2007. Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids 76(5): 293-297. (Pubitemid 46803263)
24. Lasztity N, Hamvas J, Biró L, Németh E , Marosvölgyi T, Decsi T, Pap A , Antal M. 2005. Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis -a prospective randomized clinical trial. Clin Nutr 24(2):198-205. (Pubitemid 40392802)
25. McInnes GT. 2005. Lowering blood pressure for cardiovascular risk reduction. J Hypertens 23:S3-S8.
26. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T. 1982. Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J 285(6347):993-996. (Pubitemid 12018483)
27. Mori TA. 2006. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 33(9):842-846. (Pubitemid 44215141)
28. Morris MC, Sacks F, Rosner B. 1993. Does fish oil lower blood pressure -a meta-analysis of controlled trials. Circulation 88(2): 523-533. (Pubitemid 23228051)
29. Nyby MD, Hori MT, Ormsby B, Gabrielian A, Tuck ML. 2003. Eicosapentaenoic acid inhibits Ca2 + mobilization and PKC activity in vascular smooth muscle cells. Am J Hypertens 16(9 Pt 1):708-714. (Pubitemid 37175983)
30. Oostenbrug GS, Mensink RP, Hardeman MR,De VriesT, Brouns F, Hornstra G. 1997. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J Appl Physiol 83(3):746-752. (Pubitemid 27392292)
31. PriscoD, Paniccia R, Bandinelli B, Filippini M, Francalanci I, Giusti B, et al. 1998. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 91(3): 105-112. (Pubitemid 28428202)
32. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, et al. 2006. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr 83(2):221-226. (Pubitemid 44713181)
33. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, Kantola M, et al. 1988. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 48(5):1226-1232.
34. Sanders TAB, Gleason K, Griffin B, Miller GJ. 2006. Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr 95(3):525-531.
35. Sasaki N, Morisaki N, Shinomiya M, Matsuoka N, Saito Y, Wakashin M, et al. 1982. Effect of hypertension on lipid metabolism and beta-oxidation in rat aorta and brain microvessels. Artery 11(2):108-118. (Pubitemid 13112552)
36. Simon JA, Fong J, Bernert JT. 1996. Serum fatty acids and blood pressure. Hypertension 27(2):303-307. (Pubitemid 26045930)
37. Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA. 1996. Relationship to blood pressure of combinations of dietary macronutrients -findings of the multiple risk factor intervention trial (MRFIT). Circulation 94(10):2417-2423. (Pubitemid 26403567)
38. Uusitupa MIJ, Sarkkinen ES, Torpstrom J, Pietinen P, Aro A. 1994. Long-term effects of 4 fat-modified diets on blood pressure. J Hum Hypertens 8(3):209-218. (Pubitemid 24090279)
39. Wang L, Manson JE, Forman JP, Gaziano JM, Buring JE, Sesso HD. 2010. Dietary fatty acids and the risk of hypertension in middleaged and older women. Hypertension 56(4):598-604.
40. Weisinger HS, Armitage JA, Sinclair AJ, Vingrys AJ, Burns PL, Weisinger RS. 2001. Perinatal omega-3 fatty acid deficiency affects blood pressure later in life. Nat Med 7(3):258-259. (Pubitemid 32224317)
41. Weder AB. 2007. Genetics and hypertension. J Clin Hypertens 9(3): 217-223.
42. Wolk A, Furuheim M, Vessby B. 2001. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131(3):828-833. (Pubitemid 32199152)
43. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. 1995. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 52(1):39-44.
44. Yin K, Chu ZM, Beilin LJ. 1990. Effect of fish oil feeding on blood pressure and vascular reactivity in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 17(3):235-239. (Pubitemid 20119540)